CN Stock MarketDetailed Quotes

301281 Shandong Keyuan Pharmaceutical

Watchlist
  • 19.72
  • -0.20-1.00%
Market Closed Sep 11 15:00 CST
2.14BMarket Cap34.48P/E (TTM)

Shandong Keyuan Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
Total operating revenue
5.64%237.14M
17.75%146.28M
1.07%447.58M
1.86%340.68M
0.14%224.47M
9.52%124.23M
5.22%442.87M
334.44M
5.44%224.17M
113.43M
Operating revenue
5.64%237.14M
17.75%146.28M
1.07%447.58M
1.86%340.68M
0.14%224.47M
9.52%124.23M
5.22%442.87M
--334.44M
5.44%224.17M
--113.43M
Other operating revenue
102.86%646.97K
----
197.68%1.64M
----
-45.07%318.93K
----
-54.83%551.34K
----
--580.56K
----
Total operating cost
22.49%211.81M
39.64%124.46M
9.52%381.06M
6.30%276.62M
3.92%172.91M
7.52%89.13M
3.03%347.93M
260.23M
166.38M
82.9M
Operating cost
31.97%140.21M
50.02%85.6M
-9.74%236.09M
-15.40%170.83M
-20.08%106.24M
-14.67%57.06M
7.34%261.57M
--201.92M
--132.94M
--66.87M
Operating tax surcharges
67.94%4.51M
11.55%1.57M
-8.63%4.84M
0.23%3.72M
16.66%2.68M
43.29%1.4M
18.55%5.3M
--3.71M
--2.3M
--979.89K
Operating expense
11.99%34.81M
45.21%20.93M
121.15%63.4M
159.07%45.43M
222.30%31.09M
197.31%14.41M
9.78%28.67M
--17.53M
--9.65M
--4.85M
Administration expense
-10.04%18.41M
-3.61%8.51M
33.96%37.71M
35.02%30.11M
76.90%20.46M
63.99%8.83M
-27.30%28.15M
--22.3M
--11.57M
--5.38M
Financial expense
26.75%-2.22M
-35.84%-930.33K
-77.84%-4.85M
-202.22%-3.3M
-1,159.91%-3.03M
-412.41%-684.88K
-1,129.12%-2.73M
---1.09M
---240.16K
--219.22K
-Interest Income (Financial expense)
-23.84%-2.27M
---1.28M
-183.42%-3.77M
-253.33%-2.94M
-277.10%-1.84M
----
-38.11%-1.33M
---831.5K
---486.98K
----
Research and development
4.03%16.08M
8.32%8.78M
62.64%43.86M
88.13%29.83M
52.02%15.46M
76.56%8.11M
10.39%26.97M
--15.86M
--10.17M
--4.59M
Credit Impairment Loss
-165.49%-307.5K
-354.16%-1.7M
89.47%-115.01K
61.96%-659.66K
125.05%469.56K
64.98%-375.18K
-276.71%-1.09M
---1.73M
---1.87M
---1.07M
Asset Impairment Loss
-746.98%-827.11K
88.05%-2.84K
-37.26%-3.38M
91.75%-97.65K
87.29%-97.65K
52.89%-23.76K
-247.00%-2.46M
---1.18M
---768.2K
---50.43K
Other net revenue
458.02%17.13M
472.12%2.61M
319.53%13.59M
153.11%7.63M
393.93%3.07M
397.41%456.37K
-51.11%3.24M
3.01M
621.58K
91.75K
Fair value change income
-14.45%370.11K
--1.02M
--543.18K
--4.23M
--432.6K
----
----
----
----
----
Invest income
1,557.98%5.78M
--540.74K
--12.2M
--1.67M
--348.61K
----
----
----
----
----
-Including: Investment income associates
--3.61M
----
--3.08M
----
----
----
----
----
----
----
Asset deal income
578.90%77.96K
----
-9.16%345.99K
-89.44%11.48K
--11.48K
----
931.22%380.88K
--108.77K
----
----
Other revenue
531.77%12.04M
222.65%2.76M
-37.73%3.99M
-57.60%2.47M
-41.63%1.91M
-29.52%855.32K
-4.03%6.41M
--5.82M
--3.26M
--1.21M
Operating profit
-22.27%42.47M
-31.29%24.43M
-18.39%80.12M
-7.17%71.69M
-6.46%54.63M
16.09%35.55M
9.29%98.17M
77.22M
26.42%58.4M
30.62M
Add:Non operating Income
-57.33%59.03K
----
8.13%313.37K
-11.99%234.54K
-28.21%138.32K
-84.06%141.86K
-38.76%289.8K
--266.51K
--192.66K
--889.86K
Less:Non operating expense
533.01%1.79M
2,102.48%1.2M
331.80%694.89K
272.55%579.51K
105.57%282.64K
548.45%54.46K
-57.35%160.93K
--155.55K
--137.49K
--8.4K
Total profit
-25.23%40.74M
-34.82%23.23M
-18.89%79.74M
-7.75%71.34M
-6.79%54.49M
13.12%35.64M
9.32%98.3M
77.33M
26.42%58.46M
31.51M
Less:Income tax cost
43.47%4.71M
-51.97%1.71M
-61.61%2.7M
-43.46%4.79M
-55.59%3.28M
-12.50%3.55M
-40.22%7.02M
--8.47M
--7.39M
--4.06M
Net profit
-29.64%36.03M
-32.92%21.52M
-15.60%77.04M
-3.36%66.55M
0.27%51.2M
16.91%32.09M
16.77%91.28M
68.87M
27.95%51.07M
27.45M
Net profit from continuing operation
-29.64%36.03M
-32.92%21.52M
-15.60%77.04M
-3.36%66.55M
0.27%51.2M
16.91%32.09M
16.77%91.28M
--68.87M
--51.07M
--27.45M
Less:Minority Profit
---63.92K
---8.77K
----
----
----
----
----
----
----
----
Net profit of parent company owners
-29.52%36.09M
-32.90%21.53M
-15.60%77.04M
-3.36%66.55M
0.27%51.2M
16.91%32.09M
16.77%91.28M
--68.87M
27.95%51.07M
--27.45M
Earning per share
Basic earning per share
-38.32%0.3333
-64.07%0.1988
-32.14%0.76
-20.94%0.6705
-14.07%0.5404
17.72%0.5533
-17.04%1.12
--0.8481
--0.6289
--0.47
Diluted earning per share
-38.32%0.3333
-64.07%0.1988
-32.14%0.76
-20.94%0.6705
-14.07%0.5404
17.72%0.5533
-17.04%1.12
--0.8481
--0.6289
--0.47
Other composite income
Total composite income
-29.64%36.03M
-32.92%21.52M
-15.60%77.04M
-3.36%66.55M
0.27%51.2M
16.91%32.09M
16.77%91.28M
68.87M
51.07M
27.45M
Total composite income of parent company owners
-29.52%36.09M
-32.90%21.53M
-15.60%77.04M
-3.36%66.55M
0.27%51.2M
16.91%32.09M
16.77%91.28M
--68.87M
--51.07M
--27.45M
Total composite income of minority owners
---63.92K
---8.77K
----
----
----
----
----
----
----
----
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Auditor
--
--
Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)
--
--
--
Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)
--
--
--
(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022
Total operating revenue 5.64%237.14M17.75%146.28M1.07%447.58M1.86%340.68M0.14%224.47M9.52%124.23M5.22%442.87M334.44M5.44%224.17M113.43M
Operating revenue 5.64%237.14M17.75%146.28M1.07%447.58M1.86%340.68M0.14%224.47M9.52%124.23M5.22%442.87M--334.44M5.44%224.17M--113.43M
Other operating revenue 102.86%646.97K----197.68%1.64M-----45.07%318.93K-----54.83%551.34K------580.56K----
Total operating cost 22.49%211.81M39.64%124.46M9.52%381.06M6.30%276.62M3.92%172.91M7.52%89.13M3.03%347.93M260.23M166.38M82.9M
Operating cost 31.97%140.21M50.02%85.6M-9.74%236.09M-15.40%170.83M-20.08%106.24M-14.67%57.06M7.34%261.57M--201.92M--132.94M--66.87M
Operating tax surcharges 67.94%4.51M11.55%1.57M-8.63%4.84M0.23%3.72M16.66%2.68M43.29%1.4M18.55%5.3M--3.71M--2.3M--979.89K
Operating expense 11.99%34.81M45.21%20.93M121.15%63.4M159.07%45.43M222.30%31.09M197.31%14.41M9.78%28.67M--17.53M--9.65M--4.85M
Administration expense -10.04%18.41M-3.61%8.51M33.96%37.71M35.02%30.11M76.90%20.46M63.99%8.83M-27.30%28.15M--22.3M--11.57M--5.38M
Financial expense 26.75%-2.22M-35.84%-930.33K-77.84%-4.85M-202.22%-3.3M-1,159.91%-3.03M-412.41%-684.88K-1,129.12%-2.73M---1.09M---240.16K--219.22K
-Interest Income (Financial expense) -23.84%-2.27M---1.28M-183.42%-3.77M-253.33%-2.94M-277.10%-1.84M-----38.11%-1.33M---831.5K---486.98K----
Research and development 4.03%16.08M8.32%8.78M62.64%43.86M88.13%29.83M52.02%15.46M76.56%8.11M10.39%26.97M--15.86M--10.17M--4.59M
Credit Impairment Loss -165.49%-307.5K-354.16%-1.7M89.47%-115.01K61.96%-659.66K125.05%469.56K64.98%-375.18K-276.71%-1.09M---1.73M---1.87M---1.07M
Asset Impairment Loss -746.98%-827.11K88.05%-2.84K-37.26%-3.38M91.75%-97.65K87.29%-97.65K52.89%-23.76K-247.00%-2.46M---1.18M---768.2K---50.43K
Other net revenue 458.02%17.13M472.12%2.61M319.53%13.59M153.11%7.63M393.93%3.07M397.41%456.37K-51.11%3.24M3.01M621.58K91.75K
Fair value change income -14.45%370.11K--1.02M--543.18K--4.23M--432.6K--------------------
Invest income 1,557.98%5.78M--540.74K--12.2M--1.67M--348.61K--------------------
-Including: Investment income associates --3.61M------3.08M----------------------------
Asset deal income 578.90%77.96K-----9.16%345.99K-89.44%11.48K--11.48K----931.22%380.88K--108.77K--------
Other revenue 531.77%12.04M222.65%2.76M-37.73%3.99M-57.60%2.47M-41.63%1.91M-29.52%855.32K-4.03%6.41M--5.82M--3.26M--1.21M
Operating profit -22.27%42.47M-31.29%24.43M-18.39%80.12M-7.17%71.69M-6.46%54.63M16.09%35.55M9.29%98.17M77.22M26.42%58.4M30.62M
Add:Non operating Income -57.33%59.03K----8.13%313.37K-11.99%234.54K-28.21%138.32K-84.06%141.86K-38.76%289.8K--266.51K--192.66K--889.86K
Less:Non operating expense 533.01%1.79M2,102.48%1.2M331.80%694.89K272.55%579.51K105.57%282.64K548.45%54.46K-57.35%160.93K--155.55K--137.49K--8.4K
Total profit -25.23%40.74M-34.82%23.23M-18.89%79.74M-7.75%71.34M-6.79%54.49M13.12%35.64M9.32%98.3M77.33M26.42%58.46M31.51M
Less:Income tax cost 43.47%4.71M-51.97%1.71M-61.61%2.7M-43.46%4.79M-55.59%3.28M-12.50%3.55M-40.22%7.02M--8.47M--7.39M--4.06M
Net profit -29.64%36.03M-32.92%21.52M-15.60%77.04M-3.36%66.55M0.27%51.2M16.91%32.09M16.77%91.28M68.87M27.95%51.07M27.45M
Net profit from continuing operation -29.64%36.03M-32.92%21.52M-15.60%77.04M-3.36%66.55M0.27%51.2M16.91%32.09M16.77%91.28M--68.87M--51.07M--27.45M
Less:Minority Profit ---63.92K---8.77K--------------------------------
Net profit of parent company owners -29.52%36.09M-32.90%21.53M-15.60%77.04M-3.36%66.55M0.27%51.2M16.91%32.09M16.77%91.28M--68.87M27.95%51.07M--27.45M
Earning per share
Basic earning per share -38.32%0.3333-64.07%0.1988-32.14%0.76-20.94%0.6705-14.07%0.540417.72%0.5533-17.04%1.12--0.8481--0.6289--0.47
Diluted earning per share -38.32%0.3333-64.07%0.1988-32.14%0.76-20.94%0.6705-14.07%0.540417.72%0.5533-17.04%1.12--0.8481--0.6289--0.47
Other composite income
Total composite income -29.64%36.03M-32.92%21.52M-15.60%77.04M-3.36%66.55M0.27%51.2M16.91%32.09M16.77%91.28M68.87M51.07M27.45M
Total composite income of parent company owners -29.52%36.09M-32.90%21.53M-15.60%77.04M-3.36%66.55M0.27%51.2M16.91%32.09M16.77%91.28M--68.87M--51.07M--27.45M
Total composite income of minority owners ---63.92K---8.77K--------------------------------
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ----Unqualified opinion------Unqualified opinion------
Auditor ----Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)------Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg